Navigation Links
Growth factor protects key brain cells in Alzheimer's models
Date:2/8/2009

Memory loss, cognitive impairment, brain cell degeneration and cell death were prevented or reversed in several animal models after treatment with a naturally occurring protein called brain-derived neurotrophic factor (BDNF). The study by a University of California, San Diego-led team published in the February 8, 2009 issue of Nature Medicine shows that BDNF treatment can potentially provide long-lasting protection by slowing, or even stopping the progression of Alzheimer's disease in animal models.

"The effects of BDNF were potent," said Mark Tuszynski, MD, PhD, professor of neurosciences at the UC San Diego School of Medicine and neurologist at the Veterans Affairs San Diego Health System. "When we administered BDNF to memory circuits in the brain, we directly stimulated their activity and prevented cell death from the underlying disease."

BDNF is normally produced throughout life in the entorhinal cortex, a portion of the brain that supports memory. Its production decreases in the presence of Alzheimer's disease. For these experiments, the researchers injected the BDNF gene or protein in a series of cell culture and animal models, including transgenic mouse models of Alzheimer's disease; aged rats; rats with induced damage to the entorhinal cortex; aged rhesus monkeys, and monkeys with entorhinal cortex damage.

In each case, when compared with control groups not treated with BDNF, the treated animals demonstrated significant improvement in the performance of a variety of learning and memory tests. Notably, the brains of the treated animals also exhibited restored BDNF gene expression, enhanced cell size, improved cell signaling, and activation of function in neurons that would otherwise have degenerated, compared to untreated animals. These benefits extended to the degenerating hippocampus where short-term memory is processed, one of the first regions of the brain to suffer damage in Alzheimer's disease.

The
'/>"/>

Contact: Debra Kain
ddkain@ucsd.edu
619-543-6163
University of California - San Diego
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Masimo to Present at the Roth Capital Partners 21st Annual OC Growth Stock Conference
2. CardioDynamics Reports Eighth Consecutive Quarterly Revenue Increase Over Prior Year and 12% Revenue Growth in 2008
3. Recession-Proof Your Career: High Job Growth Expected for Rehab Therapists
4. Hill-Rom Reports First Quarter Revenue Growth of 3.0 Percent to $352 Million and Earnings Per Fully Diluted Share From Continuing Operations of $0.23, an Increase of 15.0 Percent From the Prior Year
5. Align Technology Executives to Present at ROTH 21st Annual OC Growth Stock Conference
6. Cielo MedSolutions Announces Strong Revenue Growth in 2008
7. US Cancer Pain Market to Reach $5 Billion by 2018 - Cancer Patient Growth Drives Value
8. Shengtai Pharmaceutical to Present at Roth 21st Annual OC Growth Stock Conference
9. Growth hormone treatment after weight loss surgery prevents loss of muscle mass
10. New insights into growth factors role in brain development
11. Haemonetics Reports Double Digit Growth in Revenue, Operating Income, and EPS for the Third Quarter Fiscal 2009

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...PRNewswire/ -- Menopause - it,s an unavoidable par...f uncomfortable symptoms that negatively impact qu...s, weight gain , night sweats and lethargy are ju... and perimenopause. What,s worse, menopause signs... actual menopause occurs (perimenopause), and can ...
(Date:11/30/2009)...Uses Tent To Simulate High Altitude, Low O2 Condit...wire/ -- Distance runners who live at high altitud...ir performance during races in areas that are at s... from fatigue, improve their exercise performance ...? ,, That is the question being studied among 1...
(Date:11/30/2009)...PRNewswire/ -- The launch of Invivo Corporation,s ...rst FDA-cleared, fully-automated morphological sys...t of suspicious breast lesions. The ONCAD system w...iety of North America 2009 Annual Meeting in Chica...perts in breast MRI, ONCAD for DynaCAD uses a pate...
(Date:11/30/2009)...results in animals , , MONDAY, Nov. 30...ggest that stem cells from transplanted human-deri...g and heart disorders. , Scientists already kn...ong list of different kinds of cells in the labora...ter in Seoul, Korea, co-author of one of the studi...
(Date:11/30/2009)...ire/ --- Salon Leau announced today they are hosti... raise funds and create positive impact in the fig...ds from each haircut and or color will be donated ...alon Leau has been serving the posh Washington DC ...widely recognized for her innovation in color, cut...
Breaking Medicine News(10 mins):Health News:Anti-Aging Institute of California Offers New Natural Solution for Menopause Symptoms 2Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 2Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 3Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 4Health News:New Breast MRI Technology Enables Enhanced Breast Cancer Detection 2Health News:New Breast MRI Technology Enables Enhanced Breast Cancer Detection 3Health News:Georgetown Hair Salon Helps St. Jude Find A Cure 2
... Insurance Coverage Exclusions for,Pre-existing Co..., WASHINGTON, Oct. 26 The National Patient,Advoc...ganization dedicated,to the mission of creating av...(D-WV) for acting to protect Americans at,risk of ...
...iental,Bioengineering, Inc. (NYSE: AOB ), a leadi...rmaceutical and nutraceutical products in China, t...l investor conferences in,November. The Company w...nagement is currently scheduled to present at,1:55...
...d Companies Control Health Care Costs, DALLAS, Oc...cs" Kenneth H. Cooper, M.D., M.P.H., Cooper Aerobi...r acquisition in the company,s 37-year,history. Co...Benefits merges traditional employee benefits cons...
...n Jack Group, Inc.,(MattsonJack) announces the rel... Database(TM) is designed to help clients make str...g of the importance of mutually,exclusive and over...nd Comorbidity Database(TM) -- Med 2.0, which feat...
...Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ), the...nced that data from a 12-month study of DAYTRANATM...on Deficit Hyperactivity Disorder (ADHD) patch, de...esented today at a major scientific and educationa...
...ty is a societal problem that needs to be solved. ...patitis or NASH, is just one of the many complicat...or NASH are limited, and therefore there is an unm...ing hand to potentially aid in abolishing the occu...
Other Medicine News:Health News:National Patient Advocate Foundation Hails Senator Rockefeller for Introducing Bill Protecting Patient Access to Health Coverage 2Health News:American Oriental Bioengineering Announces Participation in November Healthcare Conferences 2Health News:An Industry First: New Cooper Health Company Makes Group Employee Benefits Consulting and Wellness Program Design a Package Deal 2Health News:An Industry First: New Cooper Health Company Makes Group Employee Benefits Consulting and Wellness Program Design a Package Deal 3Health News:An Industry First: New Cooper Health Company Makes Group Employee Benefits Consulting and Wellness Program Design a Package Deal 4Health News:The Mattson Jack Group, Inc. Announces the Release of the New Comorbidity Database(TM) 2Health News:Long-term 12-month safety data on ADHD patch DAYTRANA 2Health News:Attenuation of NASH by stimulation of free fatty acid metabolism 2
(Date:11/30/2009)...PRNewswire-FirstCall/ -- NightHawk Radiology Servi...o radiology groups and hospitals throughout the Un...Assurance (QA) program to foster better communicat... and to deliver superior patient care. ,, Nig... program in several presentations at RSNA 2009. Ni...
(Date:11/30/2009)...re/ -- Reportlinker.com announces that a new marke..., Surgical Incision Closures - Global Trends ...al-Incision-Closures---Global-Trends.html ,, S...gnificance, due to the millions of surgical proced...es such as cardiology, obstetrics/gynecology, orth...
(Date:11/30/2009)...RNewswire/ -- Cytokine PharmaSciences, Inc. today ...I-2364, its orally active, small-molecule inhibito...lammatory cytokines. Results of the safety and to...eers confirm the safety of this compound in initia...ts completed the study, including those receiving ...
Breaking Medicine Technology:NightHawk Radiology Launches Redesigned Quality Assurance Program 2Reportlinker Adds Surgical Incision Closures - Global Trends 2Reportlinker Adds Surgical Incision Closures - Global Trends 3Reportlinker Adds Surgical Incision Closures - Global Trends 4Reportlinker Adds Surgical Incision Closures - Global Trends 5Reportlinker Adds Surgical Incision Closures - Global Trends 6Reportlinker Adds Surgical Incision Closures - Global Trends 7Cytokine PharmaSciences Completes Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364 2Young leukemia and lymphoma patients live longer today than in years past 55090 1Young leukemia and lymphoma patients live longer today than in years past 55090 2The Eli and Edythe Broad Foundation recommit to gastroenterologys future 55086 1The Eli and Edythe Broad Foundation recommit to gastroenterologys future 55086 2U M researchers discover therapeutic target that could help patients with pulmonary fibrosis 55083 1U M researchers discover therapeutic target that could help patients with pulmonary fibrosis 55083 2
...l 2 Novo Nordisk today announced that the Endocri...the United States Food and Drug Administration (FD...ted to liraglutide, a once-daily human GLP-1 analo...ns related to the risk profile of liraglutide. , ...bers supported that appropriate evidence of cardio...
...2 Rib-X Pharmaceuticals, Inc. ("Rib-X" or the "Co...e discovery and development of novel antibiotics f...s, today announced that its lead compound, delaflo...tors for the 8th annual report on "100 Great Inves...ue. , , R&D Directions is a leading pharmaceu...
Other Medicine Technology:Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes 2Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes 3Rib-X Pharmaceuticals Novel Antibiotic Delafloxacin Named One of R&D Directions 100 Great Investigational Drugs of 2009 2Rib-X Pharmaceuticals Novel Antibiotic Delafloxacin Named One of R&D Directions 100 Great Investigational Drugs of 2009 3Rib-X Pharmaceuticals Novel Antibiotic Delafloxacin Named One of R&D Directions 100 Great Investigational Drugs of 2009 4
Rutner Universal Wedge Ureteral Catheter
...njection of contrast medium, anesthetic gel, and/o...minates the need for multiple catheterizations. Th...atic passage into and through the ureter. AQ is a ...ctivated, attracts and holds water and other liqui...
Whistle-tip Ureteral Catheters (Left Ureter)
Whistle-tip
Medicine Products: